Hepatitis Monthly

Published by: Kowsar

Serum Iron Markers in Patients With Chronic Hepatitis C Infection

Codruta Vagu 1 , Camelia Sultana 2 , 3 and Simona Ruta 2 , 3 , *
Authors Information
1 Department of Virology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2 Emergent Diseases Department, Stefan S. Nicolau Institute of Virology, Bucharest, Romania
3 Discipline of Biochemistry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Article information
  • Hepatitis Monthly: October 01, 2013, 13 (10); e13136
  • Published Online: October 5, 2013
  • Article Type: Brief Report
  • Received: June 24, 2013
  • Revised: September 12, 2013
  • Accepted: September 23, 2013
  • DOI: 10.5812/hepatmon.13136

To Cite: Vagu C, Sultana C, Ruta S. Serum Iron Markers in Patients With Chronic Hepatitis C Infection, Hepat Mon. 2013 ; 13(10):e13136. doi: 10.5812/hepatmon.13136.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussions
Acknowledgements
Footnotes
References
  • 1. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res. 2007; 38(6): 606-11[DOI][PubMed]
  • 2. Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007; 147(10): 677-84[PubMed]
  • 3. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000; 284(4): 450-6[PubMed]
  • 4. Franchini M, Targher G, Capra F, Montagnana M, Lippi G. The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int. 2008; 2(3): 335-40[DOI][PubMed]
  • 5. Mitsuyoshi H, Yasui K, Yamaguchi K, Minami M, Okanoue T, Itoh Y. Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C. Int J Hepatol. 2013; 2013: 686420[DOI][PubMed]
  • 6. Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002; 97(1): 1-4[DOI][PubMed]
  • 7. Fabris C, Toniutto P, Scott CA, Falleti E, Avellini C, Del Forno M, et al. Serum iron indices as a measure of iron deposits in chronic hepatitis C. Clin Chim Acta. 2001; 304(1-2): 49-55[PubMed]
  • 8. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004; 99(2): 286-91[PubMed]
  • 9. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000; 31(4): 1014-8[DOI][PubMed]
  • 10. Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, et al. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol. 2008; 32(6 Suppl 1): 8-21[DOI][PubMed]
  • 11. Price L, Kowdley KV. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol. 2009; 23(12): 822-8[PubMed]
  • 12. Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat. 2008; 15(7): 498-507[DOI][PubMed]
  • 13. Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005; 25(4): 433-49[DOI][PubMed]
  • 14. Buyukasik NS, Nadir I, Akin FE, Cakal B, Kav T, Ersoy O, et al. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description. Turk J Gastroenterol. 2011; 22(6): 606-11[PubMed]
  • 15. Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, Yamamoto M, et al. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol. 2007; 22(11): 1886-93[DOI][PubMed]
  • 16. Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, et al. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology. 2012; 55(4): 1038-47[DOI][PubMed]
  • 17. Liu H, Trinh TL, Dong H, Keith R, Nelson D, Liu C. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 18. Guyader D, Thirouard AS, Erdtmann L, Rakba N, Jacquelinet S, Danielou H, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2007; 46(4): 587-95[DOI][PubMed]
  • 19. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010; 139(2): 393-408[DOI][PubMed]
  • 20. Cho H, Lee HC, Jang SK, Kim YK. Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes. 2008; 37(2): 154-60[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments